S. A. Sardalova, M. Rubanskaya, A. S. Temniy, O. A. Kapkova, O. A. Ignatenko, А. P. Kazantsev, S. Mikhailova, D. V. Rybakova, Kh. I. Jumaniyozov, P. A. Kerimov, M. А. Rubanskiy, A. Ryabov, K. Figurin
{"title":"膀胱前列腺切除术后泌尿生殖器横纹肌肉瘤晚期并发症一例","authors":"S. A. Sardalova, M. Rubanskaya, A. S. Temniy, O. A. Kapkova, O. A. Ignatenko, А. P. Kazantsev, S. Mikhailova, D. V. Rybakova, Kh. I. Jumaniyozov, P. A. Kerimov, M. А. Rubanskiy, A. Ryabov, K. Figurin","doi":"10.17650/1726-9776-2020-16-4-155-159","DOIUrl":null,"url":null,"abstract":"About 20—25 % of all rhabdomyosarcomas in children are located in the urogenital zone. Due to introduction of new drug treatment protocols and the use of radiation therapy, most patients are cured by conservative methods. Only about 20 % of patients undergo surgical treatment, significant number of which are underwent organ-preserving operations. In those cases when the tumor has resistance to conservative treatment, when there is a residual tumor or relapse of the disease develops, radical organ-resecting operations are considered. Among the methods of urine derivation after cystectomy, preference is given to options that allow patients to carry out urine excretion voluntary: the formation of heterotopic reservoirs connected to the urethra or opening on the skin surfaces, which are constructed from different parts of the intestine. A clinical example of late postoperative complication is presented — a calculi formation within the pouch 7 years after radical cystprostatectomy with continent urinary diversion in a patient operated for urogenital rhabdomyosarcoma.","PeriodicalId":42924,"journal":{"name":"Onkourologiya","volume":"1 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2021-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An example of late postoperative complications in a patient with urogenital rhabdomyosarcoma after cystprostatectomy\",\"authors\":\"S. A. Sardalova, M. Rubanskaya, A. S. Temniy, O. A. Kapkova, O. A. Ignatenko, А. P. Kazantsev, S. Mikhailova, D. V. Rybakova, Kh. I. Jumaniyozov, P. A. Kerimov, M. А. Rubanskiy, A. Ryabov, K. Figurin\",\"doi\":\"10.17650/1726-9776-2020-16-4-155-159\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"About 20—25 % of all rhabdomyosarcomas in children are located in the urogenital zone. Due to introduction of new drug treatment protocols and the use of radiation therapy, most patients are cured by conservative methods. Only about 20 % of patients undergo surgical treatment, significant number of which are underwent organ-preserving operations. In those cases when the tumor has resistance to conservative treatment, when there is a residual tumor or relapse of the disease develops, radical organ-resecting operations are considered. Among the methods of urine derivation after cystectomy, preference is given to options that allow patients to carry out urine excretion voluntary: the formation of heterotopic reservoirs connected to the urethra or opening on the skin surfaces, which are constructed from different parts of the intestine. A clinical example of late postoperative complication is presented — a calculi formation within the pouch 7 years after radical cystprostatectomy with continent urinary diversion in a patient operated for urogenital rhabdomyosarcoma.\",\"PeriodicalId\":42924,\"journal\":{\"name\":\"Onkourologiya\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2021-02-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Onkourologiya\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/1726-9776-2020-16-4-155-159\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onkourologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1726-9776-2020-16-4-155-159","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
An example of late postoperative complications in a patient with urogenital rhabdomyosarcoma after cystprostatectomy
About 20—25 % of all rhabdomyosarcomas in children are located in the urogenital zone. Due to introduction of new drug treatment protocols and the use of radiation therapy, most patients are cured by conservative methods. Only about 20 % of patients undergo surgical treatment, significant number of which are underwent organ-preserving operations. In those cases when the tumor has resistance to conservative treatment, when there is a residual tumor or relapse of the disease develops, radical organ-resecting operations are considered. Among the methods of urine derivation after cystectomy, preference is given to options that allow patients to carry out urine excretion voluntary: the formation of heterotopic reservoirs connected to the urethra or opening on the skin surfaces, which are constructed from different parts of the intestine. A clinical example of late postoperative complication is presented — a calculi formation within the pouch 7 years after radical cystprostatectomy with continent urinary diversion in a patient operated for urogenital rhabdomyosarcoma.
期刊介绍:
The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.